A detailed history of Blue Square Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Blue Square Asset Management, LLC holds 360 shares of LLY stock, worth $271,227. This represents 0.17% of its overall portfolio holdings.

Number of Shares
360
Previous 360 -0.0%
Holding current value
$271,227
Previous $325,000 2.15%
% of portfolio
0.17%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $189,068 - $222,886
360 New
360 $209,000
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $165,264 - $205,094
735 New
735 $203,000
Q3 2020

Nov 10, 2020

SELL
$146.22 - $169.13 $107,471 - $124,310
-735 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $100,268 - $120,672
735 New
735 $121,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Blue Square Asset Management, LLC Portfolio

Follow Blue Square Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Square Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Square Asset Management, LLC with notifications on news.